ResearcherUniversity of SalernoActive in the last 2 years
Raffaella Belvedere
Matched on ORCID iD 0000-0002-5036-7869; OpenAlex author ID A5034729165. Sources: OpenAlex.
Their work
- Papers
- 9 (first author 4, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 3
2016: 1 paper · 2017: none · 2018: 2 papers · 2019: none · 2020: 2 papers · 2021: 2 papers · 2022: none · 2023: none · 2024: 1 paper · 2025: none · 2026: 1 paper
Papers 9
- A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Transition in Pancreatic Cancer Cells Lacking… Co-author DOI 10.3390/cells15040386↗
- Correction: Pessolano et al. Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro… First author DOI 10.3390/ijms25179349↗
- The Pyrazolyl-Urea Gege3 Inhibits the Activity of ANXA1 in the Angiogenesis Induced by the Pancreatic Cancer Derived EVs. Co-author DOI 10.3390/biom11121758↗
- ANXA1 Contained in EVs Regulates Macrophage Polarization in Tumor Microenvironment and Promotes Pancreatic Cancer Progression and Metastasis. First author DOI 10.3390/ijms222011018↗
- Heparan sulfate binds the extracellular Annexin A1 and blocks its effects on pancreatic cancer cells. Co-author DOI 10.1016/j.bcp.2020.114252↗
- Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenvironment, through Interaction with the Formy… First author DOI 10.3390/cells9122719↗
- miR-196a Is Able to Restore the Aggressive Phenotype of Annexin A1 Knock-Out in Pancreatic Cancer Cells by CRISPR/Cas9 Genome Editing. Co-author DOI 10.3390/ijms19071967↗
- Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesicles Effects as Evidenced in the In Vitro MIA PaCa-2 Model System. First author DOI 10.3390/ijms19123878↗
- Annexin A1 contributes to pancreatic cancer cell phenotype, behaviour and metastatic potential independently of Formyl Peptide Receptor pathway. Co-author DOI 10.1038/srep29660↗
Closest collaborators
The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Antonello Petrella · 9 shared papers, 2016–2026 · strength 1.28
- Paper A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Trans… DOI 10.3390/cells15040386↗
- Paper Correction: Pessolano et al. Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesic… DOI 10.3390/ijms25179349↗
- Paper The Pyrazolyl-Urea Gege3 Inhibits the Activity of ANXA1 in the Angiogenesis Induced by the Pancreatic Cancer Derived EV… DOI 10.3390/biom11121758↗
- Nunzia Novizio · 5 shared papers, 2020–2026 · strength 0.84
- Paper A Thiadiazolopyrimidinone-Based Molecule Targeting Annexin A6 Impairs Cell Motility and Epithelial-to-Mesenchymal Trans… DOI 10.3390/cells15040386↗
- Paper The Pyrazolyl-Urea Gege3 Inhibits the Activity of ANXA1 in the Angiogenesis Induced by the Pancreatic Cancer Derived EV… DOI 10.3390/biom11121758↗
- Paper ANXA1 Contained in EVs Regulates Macrophage Polarization in Tumor Microenvironment and Promotes Pancreatic Cancer Progr… DOI 10.3390/ijms222011018↗
- Emanuela Pessolano · 6 shared papers, 2018–2024 · strength 0.73
- Paper Correction: Pessolano et al. Annexin A1 May Induce Pancreatic Cancer Progression as a Key Player of Extracellular Vesic… DOI 10.3390/ijms25179349↗
- Paper ANXA1 Contained in EVs Regulates Macrophage Polarization in Tumor Microenvironment and Promotes Pancreatic Cancer Progr… DOI 10.3390/ijms222011018↗
- Paper Annexin A1 Released in Extracellular Vesicles by Pancreatic Cancer Cells Activates Components of the Tumor Microenviron… DOI 10.3390/cells9122719↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.